Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 2003, p. 7122-7133, Vol. 23, No. 20
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.20.7122-7133.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Biological Sciences, Columbia University, New York, New York 10025,1 Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115,3 Howard Hughes Medical Institute, Department of Biochemistry and Molecular Biophysics, Center for Neurobiology and Behavior, Columbia University, New York, New York 100322
Received 20 March 2003/ Returned for modification 9 May 2003/ Accepted 7 July 2003
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
In their activated GTP-bound states, the Rho GTPases bind to target proteins that mediate their various biological functions (63). Among the targets that have been identified for the Rho GTPases, the p21 activated kinase (PAK) family of serine/threonine kinases are thought to have important roles in regulating cell growth and morphology (4, 16, 17, 31, 51). The PAKs fall into two categories based on their amino acid sequences. The group A PAKs, consisting of mammalian PAK1, PAK2, and PAK3, are similar to each other throughout their entire sequences. They contain an amino-terminal GTPase-binding domain (GBD), which binds to activated Rac or Cdc42, and a carboxyl-terminal kinase domain. Although expression of the group A PAKs leads to changes in cell morphology, several studies have shown that they may not be directly required for all of the cytoskeletal rearrangements triggered by Cdc42 and Rac (40, 52). Their exact roles in Rho GTPase signaling pathways, therefore, remain to be fully clarified.
The second category of PAKs, group B, consists of human PAK4, PAK5, and PAK6. PAK4 is ubiquitously expressed (1), PAK5 is expressed primarily in the brain and pancreas (15), and PAK6 is expressed in the testes, prostate, and brain (35, 69). PAK4, -5, and -6 are highly similar to each other throughout their GBD and kinase domains but share only approximately 50% identity with the group A PAKs in these domains. Outside of the GBD and kinase domains, the group B PAKs are completely different from each other and from the group A PAKs. PAK4 was the first member of the group B PAKs to be identified (1). It binds preferentially to activated Cdc42, although it also binds to activated Rac (1, 48). In contrast to the other PAKs, PAK4 can promote filopodia formation in response to Cdc42 in several cell types, including fibroblasts, and this is dependent on its kinase activity and on its binding to activated Cdc42 (1). In neuroblastoma cells, activated PAK4 can also promote neurite outgrowth, a process which requires Cdc42 activation and filopodia formation (15). In fibroblasts, activated PAK4 decreases adhesion to the extracellular matrix and promotes proliferation, leading to anchorage-independent growth (48), which may explain why its overexpression is associated with tumorigenesis (10). PAK4 is also thought to be directly involved in cell migration, and this may be mediated specificaly through the integrin ß5 subunit (73). The extracellular stimuli that activate PAK4 and substrates that are phosphorylated by PAK4 are only beginning to be elucidated. PAK4, for example, was shown to be activated by the cytokine HGF (68), and its substrates include the cytoskeletal regulatory protein LIMK1 and the proapoptotic protein BAD (14, 25).
Since the regulation of cell shape, adhesion, and motility are critical for all aspects of development, there has been growing interest in the physiological and developmental functions of the Rho GTPases and their target proteins. In Drosophila, the Rho GTPases have been implicated in a wide range of early developmental processes (cellularization, cytokinesis, gastrulation, and dorsal closure) (36), as well as later developmental processes (neuronal development, muscle differentiation, and the establishment of planar cell polarity) (36). The two best-characterized Drosophila PAKs are Drosophila PAK (DPAK), a group A PAK (26), and "mushroom body tiny" (MBT), a group B PAK similar to PAK4 (41). DPAK is important for dorsal closure and photoreceptor axon guidance (26, 27), and MBT is thought to be important for the development of neurons, specifically the Kenyon cells in the mushroom body (41).
In mammals and birds, most studies of the biological roles of PAKs and Rho GTPases have relied on the use of dominant-negative or activated mutants. For example, studies in which activated or dominant-negative mutants of the Rho GTPases are transfected into neurons from chicken or rat suggest an important role for the GTPases in neuronal development (9, 58). Likewise, transgenic mice expressing activated Rac in neurons have an increased number of dendritic spines (38). Whereas some important information can be obtained from such studies, the generation of loss-of-function mutants is crucial to understanding the physiological and developmental functions of these proteins in mammals. Mouse knockouts of Cdc42 and Rac1 have been analyzed, but result in early embryonic lethality (before embryonic day 6.5 [E6.5] and E9.5, respectively) (11, 55), so that information about their roles in mammalian development is still limited (11, 55). Thus far, no mouse knockouts of any of the PAK family members have been reported, so the physiological and developmental roles of these kinases in mammals are still completely unknown. Here we report on the effects of targeted disruption of PAK4 in mice. PAK4 is absolutely required for development, and PAK4-null embryos die prior to E11.5. Since PAK4-null embryos survive considerably longer than Cdc42- or Rac1-null embryos, however, we were able to examine organogenesis. The most likely cause of death in the PAK4-null embryos is a defect in the fetal heart. In addition, improper folding occurred in the caudal neural tubes of the PAK4-null embryos, resulting in the formation of two neural lumens. Most strikingly, PAK4-null embryos had severe abnormalities in the development and migration of neurons. Whereas neuronal progenitors appeared to form normally, neuronal differentiation was largely inhibited, axonal outgrowth was impaired, and neurons failed to migrate to their proper locations.
| MATERIALS AND METHODS |
|---|
|
|
|---|
GBD, and empty vector SR
were described previously (48). The empty targeting vector pPNT was described in (62). The anti-Myc antibody, anti-PAK2 (
-PAK) antibody, anti-PAK1 antibody, and horseradish peroxidase-conjugated donkey anti-goat immunoglobulin G (IgG) were obtained from Santa Cruz Biotechnology; anti-vinculin antibody and horseradish peroxidase-conjugated goat anti-mouse IgG were from Sigma. The monoclonal antibody to PAK4 was described previously (48). The anti-PAK5 antibody was generated by Covance, Inc. Fluorescein isothiocyanate (FITC)-conjugated phalloidin was obtained from Molecular Probes, and rhodamine-conjugated goat anti-mouse IgG antibody was from Pierce. Guinea pig anti-Nkx6.1, mouse anti-Pax7, guinea pig anti-olig2, mouse anti-Isl1/2, rabbit anti-Lim1/2, rabbit anti-Dbx2, mouse anti-Shh, and mouse anti-neurofilament antibodies were gifts from T. Jessell. FITC-labeled donkey anti-guinea pig, Cy3-labeled donkey anti-mouse, Cy3-labeled donkey anti-guinea pig, FITC-labeled donkey anti-mouse, and Cy5-labeled donkey anti-rabbit secondary antibodies were obtained from Jackson Immunoresearch Laboratories.
Cloning of murine PAK4 cDNA.
To isolate mouse PAK4 cDNA clones, a pair of degenerate oligonucleotide primers were synthesized based on the amino acid sequences conserved among the kinase domains of human PAK4, MBT (PAK4 Drosophila homologue), and C45B11.1 (PAK4 C. elegans homologue). The two primers corresponding to the amino acid sequences KQQRRELL and HRDIKSD were used to generate a PCR product with cDNA from NIH 3T3 cells as a template. PCR products were gel purified and subcloned. Inserts were sequenced by automatic sequencer (ABI Prism 377). A 253-bp PCR product exhibiting 90% homology to the kinase domain of human PAK4 was labeled with [
-32P]dCTP (Amersham Life Sciences) by the random prime labeling method (Prime-It II kit; Stratagene) and used as a probe to screen a mouse adult brain cDNA lambda library (in the Uni-ZAP XR vector; Stratagene) according to the standard protocol. Seven independent positive clones were excised as plasmids. The longest one contained the complete coding frame of mouse PAK4.
Construction of target vector and generation of PAK4-/- mice. To isolate PAK4 genomic sequences, a murine 129 genomic library (Genome Systems) was screened with the 253-bp degenerate PCR products. Several genomic clones were isolated, subcloned into the pBluescript vector, and mapped by standard techniques. A 3.5-kb fragment 3' to exon 1 and a 4.2-kb fragment 5' to exon 1 were sequentially subcloned into the pPNT vector in the opposite transcriptional orientation from the PGK-neo gene to generate the targeting construct pPNT-PAK4KO. The final construct pPNT-PAK4KO was verified by restriction analysis and partial sequencing. The pPNT-PAK4KO was linearized at a unique NotI site and electroporated into D3 embryonic stem (ES) cells. G418- and GANC-resistant colonies were isolated and genotyped by Southern analysis with an external DNA probe. Digestion of genomic DNA with KpnI results in a 3.5-kb fragment in the wild-type allele and a 5.3-kb fragment in the recombinant allele. Among 240 G418-resistant clones, 29 had a recombinant PAK4 allele. D3 ES cells were obtained from Richard Hynes (20). Later, the electroporations were repeated in E14 ES cells. PAK4 knockouts from both types of ES cells gave identical results.
PAK4+/- cells were injected into C57BL/6 blastocysts. Chimeric male mice displaying >50% coat color chimerism were bred to C57BL/6 females to generate F1 offspring. Germ line transmission of the targeted PAK4 allele was verified by PCR and Southern blot analysis of tail DNA from F1 offspring with agouti coat color. Heterozygotes were crossed with C57BL/6 mice, and the heterozygote progeny were interbred to obtain homozygotes. Genotypes were verified by PCR and Southern blot analysis. Embryos were generated by timed pregnancies of heterozygotes, and the genomic DNA derived from yolk sacs were genotyped.
Two lines of mice carrying the targeted PAK4 allele in the germ line were established from two independent ES cell clones. The phenotypic consequences of PAK4 deficiency appeared to be equivalent in offspring of both of these separately derived lines.
Genotyping by PCR. A competitive PCR method was used to assess the PAK4-null (PAK4-) and wild-type (PAK4+) alleles simultaneously. A reverse primer (5'-TGG TCA CTG GGA GAG GAT G-3') common to the PAK4- and PAK4+ alleles and two forward primers specific to PAK4+ (5'-CAG CAG CCA TTC AGT CTT-3') or PAK4-(5'-GGT GGA TGT GGA ATG TGT-3') were combined in the same PCR. The PCRs were heated at 94°C for 5 min and then went through 30 cycles at 94°C for 45 s, 60°C for 1 min, and 72°C for 1 min. The PCR products were analyzed on 2% agarose gel. The expected sizes of the wild-type and knockout PCR products are ca. 300 and 200 bp, respectively.
Histological analysis. Embryos generated by timed matings were isolated, fixed overnight in Bouin's solution, dehydrated, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (H&E). Yolk sacs were isolated for genotyping. Freshly dissected whole embryos were also observed and photographed by using a dissecting microscope.
Immunohistochemistry. For immunohistochemical localization of proteins, embryos were fixed with ice-cold 4% paraformaldehyde for 2 h, washed with cold phosphate-buffered saline (PBS), equilibrated with 30% sucrose in PBS at 4°C overnight, and then mounted in Tissue-Tek OCT compound and frozen by using dry ice. The embryo blocks were cut at about 12 µm per section. Proteins were stained by incubating slides with the indicated antibodies in 1% horse serum in PBS with 0.1% Triton X-100 (PBST) overnight at 4°C. After a wash with PBST, the slides were incubated with the indicated immunofluorescence-tagged secondary antibodies for 1 h at room temperature, washed again with PBST, and then mounted with Vectashield mounting medium (Vector). Images were collected on a Zeiss LSM510 confocal microscope.
ES cell culture and generation of PAK4-/- ES cells. ES cells were cultured on a uniform layer of mouse embryonic fibroblasts (MEFs) rendered quiescent by gamma irradiation. ES cells were grown in Dulbecco modified Eagle medium (Gibco-BRL) containing 15% fetal bovine serum (Gibco-BRL), 0.1 mM nonessential amino acids (Gibco-BRL), 2 mM L-glutamine (Gibco-BRL), 0.1 mM ß-mercaptoethanol (Sigma), and 100 U of penicillin-streptomycin/ml (Gibco-BRL) at 37°C and 5% CO2. To generate PAK4-/- ES cells, the PAK4+/- ES cells were grown in a high concentration of G418 (2 mg/ml). The medium was supplemented with lymphocyte inhibitory factor (1,000 U/ml; Gibco-BRL). Genomic DNA from 50 resistant clones were genotyped by Southern blotting. Six percent of the resistant cells that were analyzed had a PAK4-/- genotype.
Generation of PAK4-/- MEFs. E9.5 embryos were dissected from decidua, and all maternal tissues were removed under the dissection microscope. Yolk sacs were isolated and genotyped by PCR as described above, and each embryo was minced, treated with trypsin, and then cultured in individual wells on 24-well plates in Dulbecco modified Eagle medium containing 15% fetal bovine serum, glutamine, penicillin, and streptomycin. After confluence was reached, cells were trypsinized and replated, and nonadherent cells were removed 40 min later.
Western blots. Western blot analysis was carried out as described earlier (48). Lysates from human testes, brain, and heart were from Clontech.
Northern blots. To determine the relative expression levels of mouse PAK4 mRNA in different tissues and developmental stages, Northern analysis was performed with a mouse RNA master blot (Clontech) according to the manufacturer's protocol. A 400-bp cDNA fragment in the mouse PAK4 regulatory domain was prepared by random prime labeling method (Stratagene) to analyze the master blot.
To examine PAK6 levels, total RNA from different tissues of wild-type and PAK4-null mice was prepared by using RNAzol B (Tel-Test, Inc.). The isolated total RNA was separated and transferred to a positively charged nylon membrane (Amersham Bioscience) as described elsewhere (23). A 500 PAK6 cDNA fragment from the regulatory domain was radioactive labeled with a random primer labeling kit (Stratagene) and used to probe the membrane. The hybridization was performed in ExpressHyb solution from Clontech according to the manufacturer's protocol, and the membrane was exposed to a Kodak film at -80°C for 5 days. The same membrane was probed with radiolabeled
-actin cDNA probe as loading control.
Indirect immunofluorescence microscopy. PAK4+/+ and PAK4-/- MEFs (E9.5) grown on fibronectin-coated coverslips were starved in serum-free medium for 24 h and then fixed in 4% paraformaldehyde for 10 min at room temperature. The cells were stained with anti-vinculin monoclonal antibody (hVIN-1; Sigma) and rhodamine-conjugated anti-mouse secondary antibody and then visualized by fluorescence microscopy as described previously (48).
BrdU assays. Bromodeoxyuridine (BrdU) was injected intraperitoneally at 100 µg/g (body weight) into pregnant female mice at E9.5. The females were sacrificed 30 min after injection, and the embryos were fixed in 10% formalin, dehydrated, paraffin embedded, and sectioned for immunohistochemistry. The sections were labeled with the in situ cell proliferation Zymed BrdU staining kit according to the manufacturer's manual.
TUNEL assays. Paraffin-embedded sections were performed with TUNEL (terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling) staining by using an ApopTag peroxidase in situ apoptosis detection kit (Integrin) according to the manufacturer's manual.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
|
PAK4 knockouts have caudal neural tube defects. In addition to defects in neurite outgrowth, PAK4-null embryos had defects in neural tube development. Although the neural tube appeared normal throughout most of its length in the mutant embryos, the caudal end of the tube had an abnormal appearance. In this region, what at first appeared to be a duplication of the neural tube could be seen in PAK4-null embryos (Fig. 5A and B). In some embryos this apparent duplication could be seen even more rostrally along the neural tube. To see whether the apparent ectopic structure was indeed neural tube tissue and to verify that correct dorsal ventral patterning was established, cross sections of the neural tubes were stained with antibodies against dorsal and ventral neural tube markers. These included anti-Nkx6.1, which stains ventral neural progenitors, and anti-Pax7, which stains dorsal progenitors (6). Interestingly, correct dorsal ventral patterning occurred even in the mutant neural tubes (Fig. 5C to E), and the absence of duplicated gene expression suggests that there was single improperly folded tube rather than two separate tubes. Furthermore, staining with sonic hedgehog antibody, which stains the notochord (22), indicates that only a single notochord is present (Fig. 5F and G). Thus, rather than a true duplication, an improper folding or "pinching" appeared to occur between the ventral and dorsal parts of the caudal neural tube.
|
| DISCUSSION |
|---|
|
|
|---|
in the heart also have severe cardiac defects leading to embryonic lethality by E11.5. The GDI transgenic hearts are dilated and surrounded by a distended pericardium. Since Rho GDI
inhibits all three major members of the Rho GTPase family (66), these results suggest an important role for Rho GTPases in heart development. However, the defects in the GDI transgenic hearts are more severe than those of the PAK4 knockouts and include abnormalities in cardiac looping and septation. This is associated with a decrease in proliferation of cardiomyocytes and improper regulation of cyclin A and the cyclin-dependent kinase inhibitor p21 (66). The basis for the cardiac defect in PAK4-null embryos is not yet known. However, our results reflect the fact that properly regulated cell growth and morphogenesis are essential for normal development and suggest that changes in cell growth and morphology caused by the absence of PAK4 may contribute to improper development of the heart.
PAK4-deficient embryos also had severe defects in the nervous system, although dorsal ventral patterning of the nervous system occurred normally. Development and migration of neuronal cells was seriously impaired in the PAK4 knockouts. PAK4 mutant embryos had unusually thin neuroepithelia in the hindbrain and forebrain and a corresponding defect in neuronal differentiation and axonal outgrowth. This could be detected even in intact embryos by the appearance of a nearly translucent head and neural tube. The abnormalities in the nervous system were most likely not secondary effects due to the defect in fetal circulation because other mouse knockouts that die from cardiovascular defects at similar developmental stages do not have translucent or abnormally shaped heads (65, 70). Even the Rho GDI
transgenic embryos with the severe cardiac abnormalities described above do not have transparent heads as seen in the PAK4 knockouts (66).
To examine neuronal differentiation in detail, we focused on developing spinal cord neurons. In the developing embryo, sensory neurons and their attendant interneurons develop at the dorsal part of the neural tube, whereas motor neurons and interneurons develop in the ventral part (5). By E9.5, ventral neurons, but not dorsal neurons, are well developed in the mouse. We therefore focused on ventral motor neuron and interneuron development in the knockouts. We found that whereas neuronal progenitors formed normally, there was a defect in the differentiation and lateral migration of both motor neurons and ventral interneurons. This did not appear to be associated with the folding defect present in PAK4-null embryos because the lack of neuronal differentiation was apparent all along the neural tube and was not limited to the caudal end where the improper folding occurred.
The defect in neuronal differentiation most likely reflects the fact that PAK4 is associated with cytoskeletal changes including the formation of filopodia (1, 48), which have essential roles in the developing nervous system (3, 45, 56). Both filopodia and lamellipodia play key roles in the guidance of neuronal growth cones toward attractive cues and away from repulsive cues, and neurite extension occurs when these filopodia and lamellipodia are stabilized. Stabilization of these structures is followed by extension of new filopodia and lamellipodia so that the cycle of axon guidance and growth can continue (37, 45). Both neurite outgrowth and migration are thus largely controlled by these cytoskeletal structures. Consistent with this, Cdc42 and Rac were shown to play important roles in neurite outgrowth in cultured mammalian cells (24, 33, 49, 59, 60, 64), and Drosophila and C. elegans Cdc42 and Rac homologues have important roles in axonal extension and guidance (30, 75). Likewise, our results suggest that PAK4 has an important role in the differentiation of neurons. Interestingly, the Drosophila PAK4 homologue, MBT, is also thought to have an important role in neuronal development (41). In contrast to PAK4, however, MBT most likely has a role in regulating the growth or survival neuronal cells rather than in neuronal differentiation (41).
Association of integrins with the extracellular matrix plays a critical role in the regulation of axonal outgrowth and neuronal migration, and integrins are thought to have both positive and negative roles in neuronal migration (12, 43). Interestingly, cells overexpressing activated PAK4 have a decrease in focal adhesions (48), which are made up of integrins and accessory proteins (72). Conversely, cells isolated from PAK4 deficient embryos had a greatly increased level of focal adhesions (Fig. 4). Elevated levels of focal adhesions are likely to lead to an increase in adhesion to the extracellular matrix and could thus potentially prevent neurons from extending axonal processes and from migrating normally. It will be interesting to determine whether improper regulation of adhesion molecules in the neurons of PAK4-null embryos may be directly related to the defects in differentiation and migration.
It will also be interesting to determine which PAK4 substrates are important mediators in its role in neurite outgrowth. One likely candidate is LIM kinase. PAK4 strongly phosphorylates LIM kinase 1 (LIMK1) (14). Knockouts of LIMK1, however, have a much milder defect than the PAK4 knockouts. LIMK1 knockouts are viable and appear normal, although they have defects in spatial learning, alterations in long-term potentiation, and abnormalities in dendritic spine formation (42). Furthermore, we have found that the basal level of LIMK1 phosphorylation is not abrogated in PAK4 knockouts, and similar results were observed in the PAK5 knockouts (data not shown). These results suggest that PAK4 and PAK5 are not absolutely required for basal LIMK1 phosphorylation, although in the future it will also be important to determine whether LIMK1 phosphorylation in response to Cdc42 or Rac is altered in Pak4-null cells.
Another striking abnormality in the PAK4-null mice was what appeared to be a duplication or misfolding of the caudal portion of the neural tube. The absence of duplicated gene expression patterns and the absence of a second notochord, however, indicate that the caudal neural tubes in the PAK4 knockouts were most likely not actually duplicated. Instead, there appeared to be an alteration in neural tube constriction. One possible explanation is that abnormal proliferation and/or migration of neural epithelial cells led to the formation of what appeared to be two lumens instead of one. Proper neural tube development depends on actin reorganization (50), and therefore improper cytoskeletal organization in Pak4-null embryos could contribute to the defects in neural tube development.
It is interesting that mouse knockouts of other cytoskeletal regulatory proteins also have neural tube defects, although they are not identical to the abnormalities seen in the PAK4 knockouts. For example, approximately 30% of p190 Rho GAP-null mice have severe cranial neural tube closure defects (7). p190 Rho GAP is directly involved in regulating the activity of Rho, and it is thought to have an important role in cytoskeletal organization (57). The neural tube defects in the p190 Rho GAP-null mice appear to be associated with an abnormal accumulation of F-actin but not with an increase in apoptosis (7). Other cytoskeletal regulatory proteins have also been found to contribute to neural tube development. N-Wasp, for example, is thought to control cytoskeletal organization by inducing Arp2/3-mediated actin assembly (67). Neural tubes of N-Wasp-null embryos do close, but they appear undulated, and the neuroepithelium has a wavy appearance (53). Other examples are the Abl and Arg tyrosine kinases, which are both thought to have important roles in cytoskeletal organization. In double knockouts of Abl and Arg, neural tube closure is delayed and can be incomplete (32). In addition, the neural tubes "buckle" and part of the neuroepithelium collapses into the neural tube. This does not appear to be due to an increase in proliferation of the neuroepithelial cells but appears instead to be associated with disruption of actin filaments (32). All of these results suggest that abnormalities in cytoskeletal organization and cell shape may contribute to the abnormal morphology of the neural tube. It is interesting that the neural tubes of Pak4-null embryos did appear to close but were clearly abnormal in appearance. Since Pak4 is thought to have an important role in cytoskeletal organization, one possibility is that defects in cell morphology could cause the neuroepithelium to collapse into the lumen of the neural tube, similar to what was found with Arg and Abl double knockouts (32), and leading to the appearance of a duplicated neural tube.
Although several cytoskeletal regulatory proteins have been shown to have important roles in neural tube development, as described above, it is interesting that other types of signaling proteins have also been implicated in neural tube abnormalities that are similar to those of the Pak4 knockouts. One of the most interesting is the Wnt family of secreted proteins. In particular, caudal neural tubes in Wnt3A knockout embryos appeared quite similar to the PAK4 knockout caudal neural tubes, although in the Wnt3A knockouts the neural tubes may have a true duplication (71). In addition to an apparent caudal neural tube duplication, the Wnt3A knockouts lack caudal somites. The absence of Wnt3A is thus thought to cause cells normally destined to become mesoderm (from which somites develop) to adopt a neural fate instead (71). The PAK4 mutants did have caudal somites, but they were underdeveloped compared to the somites in wild-type embryos. Furthermore, the defects in the PAK4-null neural tubes appeared to be associated with an increased number of cells between the two lumens. PAK4 could potentially also have a role, therefore, in specifying mesodermal or neuronal fate in the caudal part of the embryo. Interestingly, we have found that activated PAK4 can stimulate expression of a TCF/LEF reporter (J. Qu and A. Minden, unpublished results), which is a target for the Wnt signaling pathway (28). Taken together, these results suggest the possibility of cross talk between PAK4 and the Wnt signaling pathway, and future experiments will be required to determine whether both pathways play similar roles in neural tube development.
In summary, these findings demonstrate that PAK4 has an essential role in animal development. Despite the presence of five other PAK family members and other Rho GTPase targets, none of these could compensate for the lack of PAK4 during development. We found that PAK4 has an essential role in the morphological development of the heart and neural tube, as well as in differentiation and migration of neurons.
.
| ACKNOWLEDGMENTS |
|---|
This work was supported by a grant from the NIH (CA76342) and an American Scientist Development Grant Award from American Heart Association to A.M. and a grant from the NIH (CA074892) to A.A.B.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Bagrodia, S., B. Derijard, R. J. Davis, and R. A. Cerione. 1995. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 270:27995-27998.
3. Bentley, D., and T. P. O'Connor. 1994. Cytoskeletal events in growth cone steering. Curr. Opin. Neurobiol. 4:43-48.[CrossRef][Medline]
4. Bishop, A. L., and A. Hall. 2000. Rho GTPase and their effector proteins. Biochem. J. 348:241-255.
5. Briscoe, J., and J. Ericson. 2001. Specification of neuronal fates in the ventral neural tube. Curr. Opin. Neurobiol. 11:43-49.[CrossRef][Medline]
6. Briscoe, J., A. Pierani, T. M. Jessell, and J. Ericson. 2000. A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube. Cell 101:435-445.[CrossRef][Medline]
7. Brouns, M. R., S. F. Matheson, K. Q. Hu, I. Delalle, V. S. Caviness, J. Silver, R. T. Bronson, and J. Settleman. 2000. The adhesion signaling molecule p190 RhoGAP is required for morphogenetic processes in neural development. Development 127:4891-4903.[Abstract]
8. Brown, J. L., L. Stowers, M. Baer, J. Trejo, S. Coughlin, and J. Chant. 1996. Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. Curr. Biol. 6:598-605.[CrossRef][Medline]
9. Brown, M. D., B. J. Cornejo, T. B. Kuhn, and J. R. Bamburg. 2000. Cdc42 stimulates neurite outgrowth and formation of growth cone filopodia and lamellipodia. J. Neurobiol. 43:352-364.[CrossRef][Medline]
10. Callow, M. G., F. Clairvoyant, S. Zhu, B. Schryver, D. B. Whyte, J. R. Bischoff, B. Jallal, and T. Smeal. 2002. Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J. Biol. Chem. 277:550-558.
11. Chen, F., L. Ma, M. C. Parrini, X. Mao, M. Lopez, C. Wu, P. W. Marks, L. Davidson, D. J. Kwiatkowski, T. Kirchhausen, S. H. Orkin, F. S. Rosen, B. J. Mayer, M. W. Kirschner, and F. W. Alt. 2000. Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability. Curr. Biol. 10:758-765.[CrossRef][Medline]
12. Clegg, D. O. 2000. Novel roles for integrins in the nervous system. Mol. Cell. Biol. Res. Commun. 3:1-7.[CrossRef][Medline]
13. Coso, O. A., M. Chiariello, J. C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J. S. Gutkind. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137-1146.[CrossRef][Medline]
14. Dan, C., A. Kelly, O. Bernard, and A. Minden. 2001. Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin. J. Biol. Chem. 276:32115-32121.
15. Dan, C., N. Nath, M. Liberto, and A. Minden. 2002. PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. Mol. Cell. Biol. 22:567-577.
16. Dan, I., N. M. Watanabe, and A. Kusumi. 2001. The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol. 11:220-230.[CrossRef][Medline]
17. Daniels, R. H., and G. M. Bokoch. 1999. p21-activated protein kinase: a crucial component of morphological signaling? Trends Biochem. Sci. 24:350-355.[CrossRef][Medline]
18. Daniels, R. H., P. S. Hall, and G. M. Bokoch. 1998. Membrane targeting of p21-activated kinase 1 (PAK1) induces neurite outgrowth from PC12 cells. EMBO J. 17:754-764.[CrossRef][Medline]
19. Dodd, J., S. B. Morton, D. Karagogeos, M. Yamamoto, and T. M. Jessell. 1988. Spatial regulation of axonal glycoprotein expression on subsets of embryonic spinal neurons. Neuron 1:105-116.[CrossRef][Medline]
20. Doetschman, T. C., H. Eistetter, M. Katz, W. Schmidt, and R. Kemler. 1985. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87:27-45.[Medline]
21. Dutartre, H., J. Davoust, J. P. Gorvel, and P. Chavrier. 1996. Cytokinesis arrest and redistribution of actin-cytoskeleton regulatory components in cells expressing the Rho GTPase CDC42Hs. J. Cell Sci. 109:367-377.[Abstract]
22. Ericson, J., P. Rashbass, A. Schedl, S. Brenner-Morton, A. Kawakami, V. van Heyningen, T. M. Jessell, and J. Briscoe. 1997. Pax6 controls progenitor cell identity and neuronal fate in response to graded Shh signaling. Cell 90:169-180.[CrossRef][Medline]
23. Fourney, R. M., Miyakoshi J., R. S. Day III, and P. M. C. 1988. Northern blotting: efficient RNA staining and transfer. Focus 10:5-7.
24. Gebbink, M. F., O. Kranenburg, M. Poland, F. P. van Horck, B. Houssa, and W. H. Moolenaar. 1997. Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: control of neuronal morphology. J. Cell Biol. 137:1603-1613.
25. Gnesutta, N., J. Qu, and A. G. Minden. 2001. The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J. Biol. Chem. 276:14414-14419.
26. Harden, N., J. Lee, H. Y. Loh, Y. M. Ong, I. Tan, T. Leung, E. Manser, and L. Lim. 1996. A Drosophila homolog of the Rac- and Cdc42-activated serine/threonine kinase PAK is a potential focal adhesion and focal complex protein that colocalizes with dynamic actin structures. Mol. Cell. Biol. 16:1896-1908.[Abstract]
27. Hing, H., J. Xiao, N. Harden, L. Lim, and S. L. Zipursky. 1999. Pak functions downstream of Dock to regulate photoreceptor axon guidance in Drosophila. Cell 97:853-863.[CrossRef][Medline]
28. Huelsken, J., and W. Birchmeier. 2001. New aspects of Wnt signaling pathways in higher vertebrates. Curr. Opin. Genet. Dev. 11:547-553.[CrossRef][Medline]
29. Jaffer, Z. M., and J. Chernoff. 2002. p21-Activated kinases: three more join the Pak. Int. J. Biochem. Cell Biol. 34:713-717.[CrossRef][Medline]
30. Kaufmann, N., Z. P. Wills, and D. Van Vactor. 1998. Drosophila Rac1 controls motor axon guidance. Development 125:453-461.[Abstract]
31. Knaus, U. G., and G. M. Bokoch. 1998. The p21Rac/Cdc42-activated kinases (PAKs). Int. J. Biochem. Cell Biol. 30:857-862.[CrossRef][Medline]
32. Koleske, A. J., A. M. Gifford, M. L. Scott, M. Nee, R. T. Bronson, K. A. Miczek, and D. Baltimore. 1998. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21:1259-12572.[CrossRef][Medline]
33. Kozma, R., S. Sarner, S. Ahmed, and L. Lim. 1997. Rho family GTPases and neuronal growth cone remodeling: relationship between increased complexity induced by Cdc42Hs, Rac1, and acetylcholine and collapse induced by RhoA and lysophosphatidic acid. Mol. Cell. Biol. 17:1201-1211.[Abstract]
34. Lamoureux, P., Z. F. Altun-Gultekin, C. Lin, J. A. Wagner, and S. R. Heidemann. 1997. Rac is required for growth cone function but not neurite assembly. J. Cell Sci. 110:635-641.[Abstract]
35. Lee, S. R., S. M. Ramos, A. Ko, D. Masiello, K. D. Swanson, M. L. Lu, and S. P. Balk. 2002. AR and ER interaction with a p21-activated kinase (PAK6). Mol. Endocrinol. 16:85-99.
35. Li, X., and A. Minden. 2003. Targeted disruption of the gene for the PAK5 kinase in mice. Mol. Cell. Biol. 23:7134-7142.
36. Lu, Y., and J. Settleman. 1999. The role of rho family GTPases in development: lessons from Drosophila melanogaster. Mol. Cell. Biol. Res. Commun. 1:87-94.[CrossRef][Medline]
37. Luo, L. 2000. Rho GTPases in neuronal morphogenesis. Nat. Rev. Neurosci. 1:173-180.[CrossRef][Medline]
38. Luo, L., T. K. Hensch, L. Ackerman, S. Barbel, L. Y. Jan, and Y. N. Jan. 1996. Differential effects of the Rac GTPase on Purkinje cell axons and dendritic trunks and spines. Nature 379:837-840.[CrossRef][Medline]
39. Luo, L., Y. J. Liao, L. Y. Jan, and Y. N. Jan. 1994. Distinct morphogenetic functions of similar small GTPases: Drosophila Drac1 is involved in axonal outgrowth and myoblast fusion. Genes Dev. 8:1787-1802.
40. Manser, E., H. Y. Huang, T. H. Loo, X. Q. Chen, J. M. Dong, T. Leung, and L. Lim. 1997. Expression of constitutively active alpha-PAK reveals effects of the kinase on actin and focal complexes. Mol. Cell. Biol. 17:1129-1143.[Abstract]
41. Melzig, J., K. H. Rein, U. Schafer, H. Pfister, H. Jackle, M. Heisenberg, and T. Raabe. 1998. A protein related to p21-activated kinase (PAK) that is involved in neurogenesis in the Drosophila adult central nervous system. Curr. Biol. 8:1223-1226.[CrossRef][Medline]
42. Meng, Y., Y. Zhang, V. Tregoubov, C. Janus, L. Cruz, M. Jackson, W. Y. Lu, J. F. MacDonald, J. Y. Wang, D. L. Falls, and Z. Jia. 2002. Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron 35:121-133.[CrossRef][Medline]
43. Milner, R., and I. L. Campbell. 2002. The integrin family of cell adhesion molecules has multiple functions within the CNS. J. Neurosci. Res. 69:286-291.[CrossRef][Medline]
44. Minden, A., A. Lin, F. X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147-1157.[CrossRef][Medline]
45. Mueller, B. K. 1999. Growth cone guidance: first steps towards a deeper understanding. Annu. Rev. Neurosci. 22:351-388.[CrossRef][Medline]
46. Novitch, B. G., A. I. Chen, and T. M. Jessell. 2001. Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2. Neuron 31:773-789.[CrossRef][Medline]
47. Pfaff, S. L., M. Mendelsohn, C. L. Stewart, T. Edlund, and T. M. Jessell. 1996. Requirement for LIM homeobox gene Isl1 in motor neuron generation reveals a motor neuron-dependent step in interneuron differentiation. Cell 84:309-320.[CrossRef][Medline]
48. Qu, J., M. S. Cammarano, Q. Shi, K. C. Ha, P. de Lanerolle, and A. Minden. 2001. Activated PAK4 regulates cell adhesion and anchorage-independent growth. Mol. Cell. Biol. 21:3523-3533.
49. Sarner, S., R. Kozma, S. Ahmed, and L. Lim. 2000. Phosphatidylinositol 3-kinase, Cdc42, and Rac1 act downstream of Ras in integrin-dependent neurite outgrowth in N1E-115 neuroblastoma cells. Mol. Cell. Biol. 20:158-172.
50. Schoenwolf, G. C., and J. L. Smith. 1990. Mechanisms of neurulation: traditional viewpoint and recent advances. Development 109:243-270.[Abstract]
51. Sells, M. A., and J. Chernoff. 1997. Emerging from the Pak: the p21-activated protein kinase family. Trends Cell Biol. 7:162-167.
52. Sells, M. A., U. G. Knaus, S. Bagrodia, D. M. Ambrose, G. M. Bokoch, and J. Chernoff. 1997. Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr. Biol. 7:202-210.
53. Snapper, S. B., F. Takeshima, I. Anton, C. H. Liu, S. M. Thomas, D. Nguyen, D. Dudley, H. Fraser, D. Purich, M. Lopez-Ilasaca, C. Klein, L. Davidson, R. Bronson, R. C. Mulligan, F. Southwick, R. Geha, M. B. Goldberg, F. S. Rosen, J. H. Hartwig, and F. W. Alt. 2001. N-WASP deficiency reveals distinct pathways for cell surface projections and microbial actin-based motility. Nat. Cell Biol. 3:897-904.[CrossRef][Medline]
54. Steven, R., T. J. Kubiseski, H. Zheng, S. Kulkarni, J. Mancillas, A. Ruiz Morales, C. W. Hogue, T. Pawson, and J. Culotti. 1998. UNC-73 activates the Rac GTPase and is required for cell and growth cone migrations in Caenorhabditis elegans. Cell 92:785-795.[CrossRef][Medline]
55. Sugihara, K., N. Nakatsuji, K. Nakamura, K. Nakao, R. Hashimoto, H. Otani, H. Sakagami, H. Kondo, S. Nozawa, A. Aiba, and M. Katsuki. 1998. Rac1 is required for the formation of three germ layers during gastrulation. Oncogene 17:3427-3433.[CrossRef][Medline]
56. Suter, D. M., and P. Forscher. 1998. An emerging link between cytoskeletal dynamics and cell adhesion molecules in growth cone guidance. Curr. Opin. Neurobiol. 8:106-116.[CrossRef][Medline]
57. Tatsis, N., D. A. Lannigan, and I. G. Macara. 1998. The function of the p190 Rho GTPase-activating protein is controlled by its N-terminal GTP binding domain. J. Biol. Chem. 273:34631-34638.
58. Threadgill, R., K. Bobb, and A. Ghosh. 1997. Regulation of dendritic growth and remodeling by Rho, Rac, and Cdc42. Neuron 19:625-634.[CrossRef][Medline]
59. Tigyi, G., D. J. Fischer, A. Sebok, F. Marshall, D. L. Dyer, and R. Miledi. 1996. Lysophosphatidic acid-induced neurite retraction in PC12 cells: neurite-protective effects of cyclic AMP signaling. J. Neurochem. 66:549-558.[Medline]
60. Tigyi, G., D. J. Fischer, A. Sebok, C. Yang, D. L. Dyer, and R. Miledi. 1996. Lysophosphatidic acid-induced neurite retraction in PC12 cells: control by phosphoinositide-Ca2+ signaling and Rho. J. Neurochem. 66:537-548.[Medline]
61. Tsuchida, T., M. Ensini, S. B. Morton, M. Baldassare, T. Edlund, T. M. Jessell, and S. L. Pfaff. 1994. Topographic organization of embryonic motor neurons defined by expression of LIM homeobox genes. Cell 79:957-970.[CrossRef][Medline]
62. Tybulewicz, V. L., C. E. Crawford, P. K. Jackson, R. T. Bronson, and R. C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 65:1153-1163.[CrossRef][Medline]
63. Van Aelst, L., and C. D'Souza-Schorey. 1997. Rho GTPases and signaling networks. Genes Dev. 11:2295-2322.
64. van Leeuwen, F. N., H. E. Kain, R. A. van der Kammen, F. Michiels, O. W. Kranenburg, and J. G. Collard. 1997. The guanine nucleotide exchange factor Tiam1 affects neuronal morphology; opposing roles for the small GTPases Rac and Rho. J. Cell Biol. 139:797-807.
65. Varfolomeev, E. E., M. Schuchmann, V. Luria, N. Chiannilkulchai, J. S. Beckmann, I. L. Mett, D. Rebrikov, V. M. Brodianski, O. C. Kemper, O. Kollet, T. Lapidot, D. Soffer, T. Sobe, K. B. Avraham, T. Goncharov, H. Holtmann, P. Lonai, and D. Wallach. 1998. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 9:267-276.[CrossRef][Medline]
66. Wei, L., K. Imanaka-Yoshida, L. Wang, S. Zhan, M. D. Schneider, F. J. DeMayo, and R. J. Schwartz. 2002. Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation. Development 129:1705-1714.
67. Welch, M. D. 1999. The world according to Arp: regulation of actin nucleation by the Arp2/3 complex. Trends Cell Biol. 9:423-427.[CrossRef][Medline]
68. Wells, C. M., A. Abo, and A. J. Ridley. 2002. PAK4 is activated via PI3K in HGF-stimulated epithelial cells. J. Cell Sci. 115:3947-3956.
69. Yang, F., X. Li, M. Sharma, M. Zarnegar, B. Lim, and Z. Sun. 2001. Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6. J. Biol. Chem. 276:15345-15353.
70. Yang, J., M. Boerm, M. McCarty, C. Bucana, I. J. Fidler, Y. Zhuang, and B. Su. 2000. Mekk3 is essential for early embryonic cardiovascular development. Nat. Genet. 24:309-313.[CrossRef][Medline]
71. Yoshikawa, Y., T. Fujimori, A. P. McMahon, and S. Takada. 1997. Evidence that absence of Wnt-3a signaling promotes neuralization instead of paraxial mesoderm development in the mouse. Dev. Biol. 183:234-242.[CrossRef][Medline]
72. Zamir, E., and B. Geiger. 2001. Molecular complexity and dynamics of cell-matrix adhesions. J. Cell Sci. 114:3583-3590.
73. Zhang, H., Z. Li, E. K. Viklund, and S. Stromblad. 2002. P21-activated kinase 4 interacts with integrin
vß5 and regulates
vß5-mediated cell migration. J. Cell Biol. 158:1287-1297.
74. Zhang, S., J. Han, M. A. Sells, J. Chernoff, U. G. Knaus, R. J. Ulevitch, and G. M. Bokoch. 1995. Rho family GTPases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1. J. Biol. Chem. 270:23934-23936.
75. Zipkin, I. D., R. M. Kindt, and C. J. Kenyon. 1997. Role of a new Rho family member in cell migration and axon guidance in Caenorhabditis elegans. Cell 90:883-894.[CrossRef][Medline]
This article has been cited by other articles: